Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosylate with low-dose propofol for painless gastroscopy
ChiCTR2100051453Phase 4Not yet recruiting
- Sponsor
- Jingzhou First People's Hospital
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam and propofol (3 arms), sponsored by Jingzhou First People's Hospital. Primary endpoint: Incidence of perioperative adverse effects. Planned start Oct 2021; status: not yet recruiting.
02
Drugs
remimazolampropofol
Beyond the preview
Go deeper on ChiCTR2100051453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100051453.